Vitamin B5 could be the key to treating a rare genetic disease, a study has found.

Published Date: 08 Mar 2023

A study by Concordia undergraduate students suggests that a simple vitamin can cure a rare but life-threatening disease.

Read Full News

Latest News

Beta-Lactam Alone Matches Combination Therapy in CAP

Adding azithromycin to beta-lactams in hospitalized patients with community-acquired pneumonia does not improve clinical efficacy, including those with SOFA scores ≥ 2.

US to Provide $50 Million More in Funding to Counter Ebola Outbreak

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

EMA Curbs Chikungunya Jab After Serious Safety Review

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

Congo Says 782 Ebola Cases Confirmed, Two New Health Zones Affected

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Latest News

Adding azithromycin to beta-lactams in hospitalized patients with community-acquired pneumonia does not improve clinical efficacy, including those with SOFA scores ≥ 2.

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

News All Time

USDA Expects to Contain Screwworm Case in Texas, Rollins Says

U.S. Agriculture Secretary Brooke ⁠Rollins said on Thursday that the USDA believes ⁠it can contain a case of ⁠New World screwworm ‌in Texas, the first case in the state...

Romania Remains Europe’s Measles Hotspot

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

WHO Launches $518 Million Plan to Curb Africa Ebola Outbreak

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

Recommended News For You

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Emicizumab in Infants With Hemophilia A: Safe and Effective Use.

A computer-aided diagnostic system for improved detection of breast cancer.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

A promising medication could slow brain tumors in children.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

Recommended Articles For You

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder 

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment 

What You Need to Know About Correcting Calcium Levels in Patients with Low Albumin  

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

2.

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

3.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

4.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

5.

No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

1.

Essential Techniques in Hematology for Better Care

2.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

3.

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies

4.

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy

5.

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot